ClinicalTrials.Veeva

Menu

Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure. (BougeTonCoeur)

R

Regional University Hospital Center (CHRU)

Status

Enrolling

Conditions

Heart Failure

Treatments

Other: Experimental arm

Study type

Interventional

Funder types

Other

Identifiers

NCT06222762
29BRC23.0022 - BOUGE TON COEUR

Details and patient eligibility

About

France has one million people with heart failure (HF). Exercise intolerance, characterised by dyspnoea, is the main clinical symptom in HF patients and a key determinant of reduced quality of life. In addition to drug and surgical treatments, cardiac rehabilitation programmes have shown benefits in heart failure patients. Lasting at least 3 weeks, these programmes improve physical abilities, quality of life and reduce the risk of hospitalisation for heart failure patients.

To date, the real challenge is no longer to prove the benefits of cardiac rehabilitation, but to find solutions to maintain its long-term effects. The transition between the end of the supervised programmes in the centre and the return home is a difficult phase for the majority of patients who do not continue regular physical activity and thus quickly lose the benefits of the programme.

To help maintain the benefits of cardiac rehabilitation, some centres offer patients programmes to continue physical activity during phase III. Although these options are often beneficial in the first few months after the end of rehabilitation compared to control groups, the long-term results are mixed. These results imply that one of these maintenance options may not be suitable for all patients. It is therefore important to propose a personalised post-rehabilitation follow-up involving the patient in the choice of physical activities to optimise the maintenance of long-term benefits.

We hypothesise that patients who receive personalised support from a sport and health professional following rehabilitation maintain long-term benefits compared to a control group who do not receive this support.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of stable heart failure with NYHA stage I, II or III
  • Participation in a cardiac rehabilitation programme
  • Patient agreement
  • Patient of legal age
  • Patient affiliated to the Social Security

Exclusion criteria

  • Patient refusal
  • Minor patients
  • Subjects under guardianship or curatorship
  • Subjects over 80 years of age at the time of inclusion

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

Commun practice
No Intervention group
Description:
Patient in the control arm will not beneficiate from a follow-up in adapted physical activities (commun practice)
Follow-up in adapted physical activities
Experimental group
Description:
Patient in the control arm will beneficiate from a follow-up in adapted physical activities
Treatment:
Other: Experimental arm

Trial contacts and locations

2

Loading...

Central trial contact

Baptiste Chéhère, PhD; Jacques Mansourati, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems